The case for withdrawal of cyclosporin after renal transplantation

Nephrology Dialysis Transplantation

Volumn 13, Issue 1, 1998, Pages 28-31

  Newstead, Charles G ^a   Johnston, Paul A ^b   Will, Eric J ^a   Davison, Alex M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN;

ARTICLE; CLINICAL TRIAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; META ANALYSIS; NEPHROTOXICITY; PRIORITY JOURNAL; SURVIVAL TIME;

CYCLOSPORINE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION;

EID: 0031973359     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.1.28     Document Type: Article

References (14)

1. Slaton JW, Kropp KA, Jhunjhunwaia JS, Selman SH. Cyclosporine versus azathioprine: a 5-year follow up of 200 consecutive cadaver renal transplant recipients. J Urol 1994: 151: 582-585
2. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-1100
3. Kasiske BL, Heim-Duthoy K, Ma JZ. Elective cyclosporine withdrawal after renal transplantation. A meta-analysis JAMA 1993; 269 (3): 395-400
4. Smith SR, Minda SA, Samsa GP et al. Late withdrawal of cyclosporine in stable renal transplant recipients. Am J Kid Dis 1995: 26 (3): 487-494
5. Rocher LL, Milford EL, Kirkman RL, Carpenter CB, Strom TB, Tilney NL. Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation 1984; 38: 669-674
6. Sweny P, Lui SF, Scoble JE, Varghese Z, Fernando ON. Moorhead JF. Conversion of stable renal allografts at one year from cyclosporin A to azathioprine: a randomized controlled study. Transplant Int 1990; 3: 19-22
7. Watson MA, Briggs JD, Junor BJR et al. Randomized trial of conversion from cyclosporin to azathioprine at one year after renai transplantation. Transplant Proc 1989; 21: 1583-1584
8. Sagalowsky AI, Reisman ME, Davidson I, Toto R, Peters PC, Helderman JH. Late cyclosporine conversion carried risk of irreversible rejection. Transplant Proc 1988; 20: 157-160
9. Heim-Duthoy KL, Chitwood KK, Tortorice KL, Massy ZA, Kasiske BL. Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kid Dis 1994; 24 (5): 846-853
10. Dunn J, Golden D, van Buren CT, Lewis RM, Lawen J, Kahan BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation 1990; 49 (2): 349-353
11. Shapiro R, Jordan M, Scantlebury V et al. FK506 in clinical kidney transplantation. Transplant Proc 1991; 23 (6): 3065-3067
12. Pedersen EB, Hansen HE, Kornerup HJ, Madsen S, Sørensen AWS. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation. Nephrol Dial Transplant 1993; 8: 250-254
13. Hollander AMJ, van Saase JLCM, Kootte AMM et al. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345: 610-614
14. Sanders CE, Curtis JJ, Julian BA et al. Tapering or discontinuing cyclosporine for financial reasons - a single-center experience. Am J Kid Dis 1993; 21: 9-15